When it was announced that Nintendo was going to be released a fighting game with motion controls called Arms, many were concerned that the response wouldn’t be up to par. Based on early impressions, however, both the game and the controls seem to be performing well. This should come as a relief to fans of the Switch who might have been worried that its rise to fame might be derailed.
It’s no secret that the Nintendo Switch is on Cloud 9 right now, with the console breaking records at every turn and enthusiasm for ownership still sky high. However, even the smallest details can turn players off from a product and wonky motion controls could be a deal breaker for many. Fortunately, Kotaku and publications like it have judged that such concerns might be unwarranted.
Now, it’s worth noting that this is one game and the controls are about as straightforward as they can be. Even so, critics are still impressed by how well the characters respond to movements in order to perform three basic attacks in Arms.
For those who don’t know, Arms is basically a fighting game where players control characters who use extendable extremities to fight. Players can use both the normal controller scheme or the Joy-Con motion control and it was the latter that the reviewers focused on.
Suffice it to say, most of those who were lucky enough to test the game and the controls were surprised at how good it was. Granted, much of the excellence in the controls had a lot to do with how smart the developers were at taking advantage of the gyro-sensors, IGN notes. Whether it is punching, blocking or throwing, everything worked smoothly.
Of course, getting the hang of the controls does involve a learning curve, so players shouldn’t assume that the game will work perfectly for them without some practice. All in all, the Switch and Arms seem to perform admirably in an area where so much could have gone wrong. Players will know soon enough when the game comes out on June 16th.


U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Tabletop particle accelerator could transform medicine and materials science
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



